vimarsana.com
Home
Live Updates
FDA Approves Amgens WEZLANA As Biosimilar to and Interchangeable With Janssens STELARA (ustekinumab) | Goodwin : vimarsana.com
FDA Approves Amgen's WEZLANA As Biosimilar to and Interchangeable With Janssen's STELARA (ustekinumab) | Goodwin
On Tuesday, October 31, FDA approved Amgen’s WEZLANA (ustekinumab-auub) as biosimilar to and interchangeable with Janssen’s STELARA (ustekinumab). WEZLANA is the first product to be...
Related Keywords
Texas ,
United States ,
,
Global Colon Cancer Association ,
Inflation Reduction Act Drug Price Negotiation Program ,
Drug Price Negotiation Program ,
Amgen ,
National Infusion Center Association ,
Inflation Reduction Act ,
Drug Price Negotiation ,
Price Negotiations ,
Western District ,
Last Thursday ,
vimarsana.com © 2020. All Rights Reserved.